Income Statement
INTELLIGENT BIO SOLUTIONS INC.
INBS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Jun 30, 2025 2025 FY | Jun 30, 2024 2024 FY | Jun 30, 2023 2023 FY | Jun 30, 2022 2022 FY | Jun 30, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
3.05 | 3.11 | 1.26 | 0.44 | 1.98 |
|
Cost of Revenue
|
1.81 | 1.69 | 0.93 | - | - |
|
Gross Profit
|
1.25 | 1.43 | 0.33 | 0.44 | 1.98 |
|
Operating Expenses
|
12.71 | 12.13 | 13.66 | 8.77 | 7.55 |
|
Research & Development
|
- | - | - | - | - |
|
Selling, General & Administrative
|
8.88 | 9.26 | 8.03 | 4.92 | 3.36 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-11.46 | -10.71 | -13.33 | -8.34 | -5.57 |
|
Non-Operating Income
|
0.09 | 0.09 | 1.93 | 0.00 | -1.49 |
|
Interest Income
|
0.10 | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | -7.06 |
|
Income Tax Expense
|
- | - | - | - | -0.02 |
|
Non-Controlling Interest
|
-0.04 | -0.03 | -0.03 | -0.03 | -0.02 |
|
Net Income
|
-10.57 | -10.16 | -10.63 | -8.31 | -7.04 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Jun 30, 2025 2025 FY | Jun 30, 2024 2024 FY | Jun 30, 2023 2023 FY | Jun 30, 2022 2022 FY | Jun 30, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-10.25 | -9.51 | -12.37 | -8.34 | -5.57 |
|
Earnings Per Share (Basic)
|
-2.00 | -6.38 | -10.58 | -0.57 | - |
|
Diluted EPS
|
-2.00 | -6.38 | -10.58 | - | - |
|
Weighted Average Shares
|
5.27 | 1.59 | 1.00 | 14.67 | - |
|
Diluted Weighted Avg Shares
|
5.27 | 1.59 | 1.00 | - | - |
|
Comprehensive Income
|
-10.18 | -10.29 | -10.42 | -8.43 | -7.33 |